Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

top border
top border
Featured Programs
Dr. Levy on Impact of Nivolumab, Pembrolizumab Approvals in NSCLC
Benjamin P. Levy, MD, assistant professor of Medicine, Hematology, and Medical Oncology at Mount Sinai Hospital, discusses how nivolumab (Opdivo) and pembrolizumab (Keytruda) have impacted the treatment landscape of non–small cell lung cancer (NSCLC). View Now

In this segment, Dean F. Bajorin, MD, and Evan Y. Yu, MD, discuss atezolizumab in muscle-invasive bladder cancer. View Now

 

Featured Video
Dr. Tan on the Risk of Novel Coronavirus for Patients With Cancer
Christina Tan, MD, MPH, state epidemiologist, assistant commissioner, New Jersey Department of Health, discusses the potential impact of the novel coronavirus on patients with cancer. View now
Gina Columbus

Gina Columbus recaps some of the top news presented each day during the 2020 Transplantation & Cellular Therapy Meetings.

Publication Bottom Border
Border Publication
x